Background <p>Many patients undergoing [<sup>18</sup>F] AlF-NOTA-FAPI-04 (<sup>18</sup>F-FAPI) PET/CT demonstrated diffuse thyroid uptake. These findings created challenges for accurate interpretation due to the limited understanding of physiological and non-oncologic causes of diffuse <sup>18</sup>F-FAPI uptake in the thyroid. This retrospective study examined patients who underwent <sup>18</sup>F-FAPI PET/CT imaging with diffuse thyroid uptake. It quantitatively assessed normal thyroid uptake, compared <sup>18</sup>F-FAPI uptake between normal and diseased thyroids, and explored potential associations with diffuse thyroid uptake. The study may improve the accuracy of <sup>18</sup>F-FAPI PET/CT interpretation for thyroid and facilitate appropriate management of diffuse thyroid uptake on <sup>18</sup>F-FAPI PET/CT.</p> Results <p>A total of 38 patients were included in this study based on the inclusion criteria. The mean SUVmax, SUVmean, and TBR of normal thyroid were 7.09 ± 3.83, 4.24 ± 2.25 and 3.93 ± 1.73, respectively. Quantitative analysis revealed no significant asymmetry in <sup>18</sup>F-FAPI uptake between the right and left thyroid lobes (SUVmax: right 6.69 ± 2.96 vs. left 6.54 ± 3.28, <i>p</i> = 0.84; SUVmean: right 4.19 ± 1.73 vs. left 4.18 ± 1.97, <i>p</i> = 0.98), consistent with the diffuse uptake pattern observed. There was no significant correlation between Hashimoto thyroiditis, serum TSH levels, and the degree of diffuse thyroid uptake (all <i>p</i> &gt; 0.05 for SUVmax, SUVmean, and TBR). Furthermore, no association was observed between sex, age, immunotherapy, and diffuse thyroid uptake (<i>p</i> &gt; 0.05).</p> Conclusions <p>Diffuse uptake of <sup>18</sup>F-FAPI in the thyroid may not significantly relate to Hashimoto thyroiditis or abnormal serum TSH levels. Lesions on <sup>18</sup>F-FAPI PET/CT scans might be hard to detect due to the moderate uptake in normal thyroid tissue.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Clinical significance of diffuse [18F] AlF-NOTA-FAPI-04 uptake in the thyroid on PET/CT imaging

  • Ying Kou,
  • Wei Diao,
  • Zhuzhong Cheng,
  • Yutang Yao

摘要

Background

Many patients undergoing [18F] AlF-NOTA-FAPI-04 (18F-FAPI) PET/CT demonstrated diffuse thyroid uptake. These findings created challenges for accurate interpretation due to the limited understanding of physiological and non-oncologic causes of diffuse 18F-FAPI uptake in the thyroid. This retrospective study examined patients who underwent 18F-FAPI PET/CT imaging with diffuse thyroid uptake. It quantitatively assessed normal thyroid uptake, compared 18F-FAPI uptake between normal and diseased thyroids, and explored potential associations with diffuse thyroid uptake. The study may improve the accuracy of 18F-FAPI PET/CT interpretation for thyroid and facilitate appropriate management of diffuse thyroid uptake on 18F-FAPI PET/CT.

Results

A total of 38 patients were included in this study based on the inclusion criteria. The mean SUVmax, SUVmean, and TBR of normal thyroid were 7.09 ± 3.83, 4.24 ± 2.25 and 3.93 ± 1.73, respectively. Quantitative analysis revealed no significant asymmetry in 18F-FAPI uptake between the right and left thyroid lobes (SUVmax: right 6.69 ± 2.96 vs. left 6.54 ± 3.28, p = 0.84; SUVmean: right 4.19 ± 1.73 vs. left 4.18 ± 1.97, p = 0.98), consistent with the diffuse uptake pattern observed. There was no significant correlation between Hashimoto thyroiditis, serum TSH levels, and the degree of diffuse thyroid uptake (all p > 0.05 for SUVmax, SUVmean, and TBR). Furthermore, no association was observed between sex, age, immunotherapy, and diffuse thyroid uptake (p > 0.05).

Conclusions

Diffuse uptake of 18F-FAPI in the thyroid may not significantly relate to Hashimoto thyroiditis or abnormal serum TSH levels. Lesions on 18F-FAPI PET/CT scans might be hard to detect due to the moderate uptake in normal thyroid tissue.